3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
13
Lymphoma, Large B-Cell, Diffuse
12
Burkitt Lymphoma
12
Lymphoma, Follicular
9
Lymphoma
7
Lymphoma, Non-Hodgkin
6
Neoplasms
5
Prostatic Neoplasms, Castration-Resistant
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell
4
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Multi-centric Castleman's Disease
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Melanoma
1
Macular dystrophy, corneal type 1
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Interventions
darolutamide
2
Docetaxel
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
Prednisone
×
30 days
×
Clear all
No trials found.